Pipeline

Our pipeline incorporates precision diagnostics with alpha and beta-emitting radionuclide therapies.

Our Pipeline

Our Pipeline

Our lead diagnostic and therapeutic programs are progressing beyond preclinical evaluation to first-in-human studies

Starting first-in-human

INDICATION

THERAPY RESISTANT SOLID TUMOURS

NTx#

NTx -010

NTx -011

NTx -043

APPLICATION

DIAGNOSTIC

THERAPEUTIC

NEXT GEN

THERAPEUTIC

DISCOVERY

PRECLINICAL

PHASE 0/1

INDICATION

THERAPY RESISTANT SOLID TUMOURS

NTx#

NTx -010

NTx -011

NTx -043

APPLICATION

DIAGNOSTIC

THERAPEUTIC

NEXT GEN

THERAPEUTIC

DISCOVERY

PRECLINICAL

PHASE 0/1

INDICATION

THERAPY

RESISTANT

SOLID

TUMOURS

NTx#

NTx -010

NTx -011

NTx -043

APPLICATION

DIAGNOSTIC

THERAPEUTIC

NEXT GEN

THERAPEUTIC

DISCOVERY

PRECLINICAL

PHASE 0/1

INDICATION

THERAPY RESISTANT SOLID TUMOURS

NTx#

NTx -010

NTx -011

NTx -043

APPLICATION

DIAGNOSTIC

THERAPEUTIC

NEXT GEN

THERAPEUTIC

DISCOVERY

PRECLINICAL

PHASE 0/1

Connect with us

Email us and keep updated on our clinical trial and pipeline development on LinkedIn.

Email us

Email us

Connect with us

Email us and keep updated on our clinical trial and pipeline development on LinkedIn.

Email us

Connect with us

Email us and keep updated on our clinical trial and pipeline development on LinkedIn.

Email us

Multi colour gradient with abstract wave form

© 2025 Nuclide Therapeutics, All rights reserved

contact@nuclidetx.com

Privacy Policy

Cookie Policy

Multi colour gradient with abstract wave form

© 2025 Nuclide Therapeutics, All rights reserved

contact@nuclidetx.com

Privacy Policy

Cookie Policy

Multi colour gradient with abstract wave form

© 2025 Nuclide Therapeutics, All rights reserved

contact@nuclidetx.com

Privacy Policy

Cookie Policy

Create a free website with Framer, the website builder loved by startups, designers and agencies.